Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

poly(ethylene glycol)-b-poly(2-(diisopropylamino)-ethyl aspartate-co-benzylamineaspartate-co-doxorubicinaspartate) nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(ethylene glycol)-b-poly(2-(diisopropylamino)-ethyl aspartate-co-benzylamineaspartate-co-doxorubicinaspartate)

mPEG-PAsp(DIP-co-BZA-co-DOX)
Type Polymer
Formula
Role raw materials

Properties

Applications

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • phosphate buffer solution
  • doxorubicin/arsenic/water/poly(ethylene glycol)-b-poly(2-(diisopropylamino)-ethyl aspartate-co-benzylamineaspartate-co-doxorubicinaspartate)
Product

poly(ethylene glycol)-b-poly(2-(diisopropylamino)-ethyl aspartate-co-benzylamineaspartate-co-doxorubicinaspartate) nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial